GPI HORIZON provides a unique approach to drug/asset price forecasting and value optimisation throughout product development
Empower your decision-making throughout development via price forecasting and detailed value profile assessment towards asset success
Where GPI HORIZON helps
The scope of GPI HORIZON spans from rapid Business Development & Licensing (BD&L) decision support to early price forecasting and full value optimisation
| No/Go decisions | Initial forecasting / base case | Pre-launch price and value optimization | |
|---|---|---|---|
 HORIZON BD & LNo/Go decisions |
EARLY PRICING & VALUE OPTIMISATION Initial forecasting / base casePre-launch price and value optimization |
||
| Price analogues |
 |
|
|
| Competitive landscape |
|
|
|
| Price corridors |
|
|
|
| Value / price forecast |
|
|
|
| Value / TPP Optimization |
|
What you get
Landscape Assessment
Take a holistic pricing and market access view when benchmarking your asset against access and pricing analogues and competitor products
Value-Price Analysis
Map your asset's value based on multi-criteria decision analysis, payer archetypes and pricing data analysis from the extensive GPI pulse database
Value Profile Optimisation
Optimise your asset’s value profile based on calibration against benchmarks and key payer considerations
Chat with us today about your price forecasting and value optimisation challenges
How GPI HORIZON helps
GPI HORIZON is your innovation partner for agile, data-driven solutions in early stage pricing and market access
Commercial Goals
Align evidence generation with commercial viability and market access priorities
Confident Estimations
Narrow down realistic and defendable price points based on a data-driven approach
Value Drivers
Evaluate your asset, think like a payer and reveal factors that drive decision-making
GPI HORIZON methodology
GPI HORIZON quantifies global payer thinking to support confident market access and price decisions through trusted platforms and expertise
Evaluate Business Development and Licensing Opportunities
Test Indication Sequences Based on Value of Disease Areas
Align Evidence Generation With Commercial Viability and Market Access
Plan Your Product Development Strategies And Optimise Pricing
Understand Value Drivers and Optimise Asset's Value Profile
